| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 8 | |
| #2 | WIPO (World Intellectual Property Organization) | 6 | |
| #3 | EPO (European Patent Office) | 5 | |
| #4 | Australia | 3 | |
| #5 | Canada | 3 | |
| #6 | China | 3 | |
| #7 | Republic of Korea | 2 | |
| #8 | Brazil | 1 | |
| #9 | Israel | 1 | |
| #10 | Singapore | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Macromolecular chemistry and polymers | |
| #4 | Measurement | |
| #5 | Organic fine chemistry | |
| #6 | Chemical engineering |
| # | Name | Total Patents |
|---|---|---|
| #1 | Guichard Gilles | 26 |
| #2 | Fremaux Juliette | 24 |
| #3 | Goudreau Sebastien | 20 |
| #4 | Zimmer Robert H | 18 |
| #5 | Venin Claire | 15 |
| #6 | Zimmer Robert | 11 |
| #7 | Mauran Laura | 5 |
| #8 | Becart Diane | 1 |
| #9 | Collie Gavin W | 1 |
| #10 | Lombardo Caterina Maria | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020148317A1 | Peptide-oligourea hybrid compounds | |
| WO2020108830A1 | Peptide-oligourea foldamer compounds and methods of their use | |
| US2019142905A1 | Peptide-oligourea foldamer compounds and methods of their use | |
| KR20200028402A | Prodrug peptides with improved pharmaceutical properties | |
| CA3021140A1 | Peptide-oligourea foldamer compounds and methods of their use | |
| EP3640263A1 | Peptide-oligourea chimeric compounds and methods of their use |